(ACOMO) Amsterdam Commodities - Overview
Stock: Spices, Nuts, Seeds, Tea, Organic
Dividends
| Dividend Yield | 5.94% |
| Yield on Cost 5y | 7.85% |
| Yield CAGR 5y | 7.38% |
| Payout Consistency | 84.4% |
| Payout Ratio | 55.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 17.2% |
| Relative Tail Risk | -12.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.68 |
| Alpha | 42.21 |
| Character TTM | |
|---|---|
| Beta | 0.036 |
| Beta Downside | 0.162 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.26% |
| CAGR/Max DD | 0.49 |
Description: ACOMO Amsterdam Commodities December 27, 2025
Acomo N.V. (ticker ACOMO) is a Rotterdam-based food-ingredients trader that sources, processes, packages and distributes both conventional and organic products across Europe, North America and other international markets. Its operations are organized into five segments: Spices & Nuts, Edible Seeds, Organic Ingredients, Tea and Food Solutions.
In the Spices & Nuts segment the company handles a broad portfolio of tropical commodities-including pepper, nutmeg, desiccated coconut, various nuts, dried fruits, dehydrated vegetables and snack-type rice crackers-serving both food-service and retail customers.
The Edible Seeds segment trades and processes seeds such as poppy, sesame, pumpkin, flax and sunflower (both in-kernel and shelled), supplying snack manufacturers, bakeries, confectioners and even wildlife-seed markets.
The Organic Ingredients segment offers a diversified range of certified organic products-cocoa, coffee, fruits, vegetables, nuts, seeds, oils and juices-capitalizing on the EU’s + 10 % annual growth in organic food consumption.
Within the Tea segment Acomo operates warehousing, blending and market-analysis capabilities, targeting the expanding specialty-tea niche that has seen a 15 % CAGR in premium blends over the past five years.
The Food Solutions segment delivers culinary and functional ingredients, plant-based formulations, wet and dry blends, and spice mixes, while also providing end-to-end services such as product development, manufacturing, packaging, distribution and inventory management.
Key financial indicators (FY 2023) show revenue of approximately €1.2 billion, an EBITDA margin of 6 %, and a 12 % YoY increase in organic-segment sales, reflecting strong demand for sustainable ingredients. The business remains sensitive to commodity-price volatility (e.g., pepper and nutmeg) and to macro-economic factors such as Euro-zone inflation, which can compress margins in the bulk-commodity segments.
Given Acomo’s diversified product mix and exposure to fast-growing plant-based and organic trends, a deeper dive into its cash-flow profile and supply-chain risk management could be worthwhile; you may find the ValueRay platform helpful for that next step.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 69.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.03 > 0.02 and ΔFCF/TA -12.12 > 1.0 |
| NWC/Revenue: 20.17% < 20% (prev 22.35%; Δ -2.19% < -1%) |
| CFO/TA 0.01 > 3% & CFO 11.9m > Net Income 69.4m |
| Net Debt (296.6m) to EBITDA (129.2m): 2.30 < 3 |
| Current Ratio: 1.90 > 1.5 & < 3 |
| Outstanding Shares: last quarter (29.7m) vs 12m ago 0.84% < -2% |
| Gross Margin: 16.26% > 18% (prev 0.14%; Δ 1612 % > 0.5%) |
| Asset Turnover: 176.0% > 50% (prev 164.9%; Δ 11.11% > 0%) |
| Interest Coverage Ratio: 5.82 > 6 (EBITDA TTM 129.2m / Interest Expense TTM 19.0m) |
Altman Z'' 4.50
| A: 0.33 (Total Current Assets 620.3m - Total Current Liabilities 327.3m) / Total Assets 883.4m |
| B: 0.26 (Retained Earnings 229.2m / Total Assets 883.4m) |
| C: 0.13 (EBIT TTM 110.4m / Avg Total Assets 825.7m) |
| D: 0.56 (Book Value of Equity 259.1m / Total Liabilities 466.7m) |
| Altman-Z'' Score: 4.50 = AA |
Beneish M -3.26
| DSRI: 0.77 (Receivables 177.5m/200.7m, Revenue 1.45b/1.27b) |
| GMI: 0.87 (GM 16.26% / 14.13%) |
| AQI: 0.83 (AQ_t 0.22 / AQ_t-1 0.27) |
| SGI: 1.15 (Revenue 1.45b / 1.27b) |
| TATA: 0.07 (NI 69.4m - CFO 11.9m) / TA 883.4m) |
| Beneish M-Score: -3.26 (Cap -4..+1) = AA |
What is the price of ACOMO shares?
Over the past week, the price has changed by -1.38%, over one month by +2.88%, over three months by +5.49% and over the past year by +48.55%.
Is ACOMO a buy, sell or hold?
What are the forecasts/targets for the ACOMO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 26.5 | 6% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 29 | 16.2% |
ACOMO Fundamental Data Overview January 28, 2026
P/E Trailing = 10.8761
P/E Forward = 11.8203
P/S = 0.5189
P/B = 1.8154
Revenue TTM = 1.45b EUR
EBIT TTM = 110.4m EUR
EBITDA TTM = 129.2m EUR
Long Term Debt = 108.5m EUR (from longTermDebt, last quarter)
Short Term Debt = 172.9m EUR (from shortTermDebt, last quarter)
Debt = 299.7m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 296.6m EUR (from netDebt column, last quarter)
Enterprise Value = 1.05b EUR (754.0m + Debt 299.7m - CCE 3.05m)
Interest Coverage Ratio = 5.82 (Ebit TTM 110.4m / Interest Expense TTM 19.0m)
EV/FCF = -36.93x (Enterprise Value 1.05b / FCF TTM -28.4m)
FCF Yield = -2.71% (FCF TTM -28.4m / Enterprise Value 1.05b)
FCF Margin = -1.96% (FCF TTM -28.4m / Revenue TTM 1.45b)
Net Margin = 4.78% (Net Income TTM 69.4m / Revenue TTM 1.45b)
Gross Margin = 16.26% ((Revenue TTM 1.45b - Cost of Revenue TTM 1.22b) / Revenue TTM)
Gross Margin QoQ = 16.84% (prev none%)
Tobins Q-Ratio = 1.19 (Enterprise Value 1.05b / Total Assets 883.4m)
Interest Expense / Debt = 2.70% (Interest Expense 8.09m / Debt 299.7m)
Taxrate = 28.03% (16.6m / 59.1m)
NOPAT = 79.5m (EBIT 110.4m * (1 - 28.03%))
Current Ratio = 1.90 (Total Current Assets 620.3m / Total Current Liabilities 327.3m)
Debt / Equity = 0.72 (Debt 299.7m / totalStockholderEquity, last quarter 414.5m)
Debt / EBITDA = 2.30 (Net Debt 296.6m / EBITDA 129.2m)
Debt / FCF = -10.43 (negative FCF - burning cash) (Net Debt 296.6m / FCF TTM -28.4m)
Total Stockholder Equity = 417.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.41% (Net Income 69.4m / Total Assets 883.4m)
RoE = 16.63% (Net Income TTM 69.4m / Total Stockholder Equity 417.3m)
RoCE = 21.00% (EBIT 110.4m / Capital Employed (Equity 417.3m + L.T.Debt 108.5m))
RoIC = 11.71% (NOPAT 79.5m / Invested Capital 678.7m)
WACC = 4.88% (E(754.0m)/V(1.05b) * Re(6.05%) + D(299.7m)/V(1.05b) * Rd(2.70%) * (1-Tc(0.28)))
Discount Rate = 6.05% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 81.65 | Cagr: 0.06%
Fair Price DCF = unknown (Cash Flow -28.4m)
EPS Correlation: -11.77 | EPS CAGR: 0.0% | SUE: 0.0 | # QB: 0
Revenue Correlation: 32.58 | Revenue CAGR: 10.76% | SUE: 0.15 | # QB: 0
EPS next Year (2026-12-31): EPS=2.15 | Chg30d=-0.000 | Revisions Net=-1 | Growth EPS=-6.3% | Growth Revenue=+4.6%